Innovative Imaging System for the Detection of Breast Cancer


You are here

Prof. Emeritus Ephraim Frei
Prof. Emeritus Ephraim Frei, a founder of electronics research at the Weizmann Institute in the 1950s, spent several decades studying the effects of magnetic fields on living tissues.


An innovative breast imaging system, T-Scan, developed on the basis of Frei's research, is manufactured and distributed by TransScan Medical. In 1999 the FDA approved T-Scan for the detection of breast cancer, citing it as a “significant medical device breakthrough.” Research is under way to apply T-Scan to the detection of skin cancer.